ISSN: 1838-7640Theranostics
Global reach, higher impact
Theranostics 2018; 8(17):4620-4632. doi:10.7150/thno.26975 This issue Cite
Research Paper
Senescent fibroblasts drive ageing pigmentation: A potential therapeutic target for senile lentigo
1. Department of Biochemistry and Molecular Biology, Ajou University, School of Medicine, Suwon, 443-721, Korea
2. Department of Dermatology, Ajou University School of Medicine, Suwon, 443-721, Korea
3. Department of Pathology, Ajou University School of Medicine, Suwon, 443-721, Korea
4. Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon,443-721, Korea
5. Institute on Ageing, Ajou University Medical Center, Suwon, 443-721, Korea
Citation:
Yoon JE, Kim Y, Kwon S, Kim M, Kim YH, Kim JH, Park TJ, Kang HY. Senescent fibroblasts drive ageing pigmentation: A potential therapeutic target for senile lentigo. Theranostics 2018; 8(17):4620-4632. doi:10.7150/thno.26975. https://www.thno.org/v08p4620.htm
Other stylesAbstract
Cutaneous ageing is an important extrinsic process that modifies the pigmentary system. Because cellular senescence is a fundamental ageing mechanism, we examined the role of senescent cells in ageing pigmentation.
Methods: Biopsies obtained from senile lentigo and perilesional normal skin were assayed for a marker of cellular senescence, p16INK4A. To determine the secretory phenotypes of senescent fibroblasts, we performed microarray, RNA sequencing and methylation array analyses in senile lentigo and senescent fibroblasts. To further investigate the impact of senescent cells on ageing-related pigmentation, an intervention that targeted senescent cells using radiofrequency was performed.
Results: In vivo, senescent fibroblasts accumulated at the sites of age-related pigmentation. Phenotype switching of the cells resulted in the repression of stromal-derived factor 1 (SDF1) by promoter methylation. SDF1 induced melanocyte differentiation via stromal-epithelial interactions, ultimately driving skin pigmentation. Furthermore, the elimination of senescent fibroblasts from pigmented skin using radiofrequency was accompanied by skin lightening, rendering it a potential target for treatment.
Conclusion: Aged pigmented skin contains an increasing proportion of senescent fibroblasts. Cells with phenotype switching exhibited a loss of SDF1, which stimulates the melanogenic process and thereby contributes to aging pigmentation. These data may promote the development of new therapeutic paradigms, such as a stroma-targeting therapy for pigmentary disorders.
Keywords: Skin pigmentation, senile lentigo, SDF1, senescent fibroblasts
Citation styles
APA
Yoon, J.E., Kim, Y., Kwon, S., Kim, M., Kim, Y.H., Kim, J.H., Park, T.J., Kang, H.Y. (2018). Senescent fibroblasts drive ageing pigmentation: A potential therapeutic target for senile lentigo. Theranostics, 8(17), 4620-4632. https://doi.org/10.7150/thno.26975.
ACS
Yoon, J.E.; Kim, Y.; Kwon, S.; Kim, M.; Kim, Y.H.; Kim, J.H.; Park, T.J.; Kang, H.Y. Senescent fibroblasts drive ageing pigmentation: A potential therapeutic target for senile lentigo. Theranostics 2018, 8 (17), 4620-4632. DOI: 10.7150/thno.26975.
NLM
Yoon JE, Kim Y, Kwon S, Kim M, Kim YH, Kim JH, Park TJ, Kang HY. Senescent fibroblasts drive ageing pigmentation: A potential therapeutic target for senile lentigo. Theranostics 2018; 8(17):4620-4632. doi:10.7150/thno.26975. https://www.thno.org/v08p4620.htm
CSE
Yoon JE, Kim Y, Kwon S, Kim M, Kim YH, Kim JH, Park TJ, Kang HY. 2018. Senescent fibroblasts drive ageing pigmentation: A potential therapeutic target for senile lentigo. Theranostics. 8(17):4620-4632.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.